TrialJournal of neurology, neurosurgery, and psychiatry2019

Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia.

Hubert H Fernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.